Oral anticoagulants reduce venous thromboembolism rates in patients on 1st-line treatment for ovarian Cancer– A quality improvement project
Authors:
- Limor HelpmanLHLimor Helpman
- Dana JosephyDJDana Josephy
- Liat ToderisLTLiat Toderis
- Victoria TkachVTVictoria Tkach
- Noa RotemNRNoa Rotem
- Daniel ShaiDSDaniel Shai
- Sonya Bar-AdonSBSonya Bar-Adon
- Hadas HegerHHHadas Heger
- Yfat KadanYKYfat Kadan
- Ana BlecherABAna Blecher
- Orgad RosenblattOROrgad Rosenblatt
- Itai YagelIYItai Yagel
- 6 August 2026
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 212, 57-63
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Incidence of venous thromboembolism in patients with advanced stage ovarian cancer undergoing neoadjuvant chemotherapy: Is it time for thromboprophylaxis?Gynecologic Oncology, 2023
- Assessing the need for venous thromboembolism prophylaxis at the time of neoadjuvant chemotherapy for ovarian cancer: A literature reviewGynecologic Oncology, 2023
- Venous Thromboembolism in Patients Receiving Neoadjuvant Chemotherapy for Advanced Ovarian Cancer and Impact on SurvivalJournal of Obstetrics and Gynaecology Canada, 2021
- Direct oral anticoagulant use in gynecologic oncology: A Society of Gynecologic Oncology Clinical Practice StatementGynecologic Oncology, 2021
- Apixaban to Prevent Venous Thromboembolism in Patients with CancerNew England Journal of Medicine, 2019
- Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trialsThe Lancet Oncology, 2018
- Dalteparin thromboprophylaxis in cancer patients at high risk for venous thromboembolism: A randomized trialThrombosis Research, 2017
- Venous thromboembolism in ovarian cancer: incidence, risk factors and impact on survivalEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2013
- Gemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancerEuropean Journal of Cancer, 2012
- Risk factors for chemotherapy‐associated venous thromboembolism in a prospective observational studyCancer, 2005